Colistin inhalation monotherapy for ventilator-associated pneumonia of Acinetobacter baumannii in prematurity

Pediatric Pulmonology

Volumn 49, Issue 4, 2014, Pages 381-388

  Kang, Chia Hao ^a   Tsai, Chih Min ^a   Wu, Tin Hsin ^a   Wu, Hsin Yi ^a   Chung, Mei Yung ^a   Chen, Chih Cheng ^a   Huang, Yi Chuan ^a   Liu, Shih Feng ^a   Liao, Da Ling ^a   Niu, Chen Kuang ^a   Lee, Chen Hsiang ^a   Yu, Hong Ren ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Acinetobacter baumannii; colistin; inhalation; pre term

Indexed keywords

AMIKACIN; CEFEPIME; CEFTAZIDIME; COLISTIN; CREATININE; HEMOGLOBIN; MEROPENEM; NEOMYCIN; SULTAMICILLIN; ANTIINFECTIVE AGENT;

ABNORMAL RESPIRATORY SOUND; ABSENCE OF SIDE EFFECTS; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; APGAR SCORE; ARTICLE; BACTEREMIA; BACTERIAL CLEARANCE; BACTERIUM ISOLATION; BIRTH WEIGHT; BLOOD PRESSURE; BREATHING RATE; CLINICAL ARTICLE; COMORBIDITY; COMPARATIVE STUDY; CONCURRENT INFECTION; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG SAFETY; DRUG TOLERANCE; FEMALE; FLUID INTAKE; FOLLOW UP; GESTATIONAL AGE; HEART RATE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; IMMUNE DEFICIENCY; INHALATIONAL DRUG ADMINISTRATION; LEUKOCYTE COUNT; LUNG DISEASE; MALE; METABOLIC DISORDER; MONOTHERAPY; NEBULIZER KIT; NEONATAL VENTILATOR; NEUROLOGIC DISEASE; NEWBORN; NEWBORN CARE; NEWBORN INTENSIVE CARE; NEWBORN MONITORING; NEWBORN MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; OXYGEN SATURATION; PREMATURITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPUTUM CULTURE; TAIWAN; THROMBOCYTE COUNT; TRACHEAL ASPIRATION PROCEDURE; TREATMENT DURATION; UREA NITROGEN BLOOD LEVEL; URINE VOLUME; VENTILATOR ASSOCIATED PNEUMONIA; ACINETOBACTER INFECTIONS; INFANT; INFANT, PREMATURE, DISEASES; MICROBIOLOGY; PNEUMONIA, VENTILATOR-ASSOCIATED;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADMINISTRATION, INHALATION; ANTI-BACTERIAL AGENTS; COLISTIN; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; PNEUMONIA, VENTILATOR-ASSOCIATED; RETROSPECTIVE STUDIES;

EID: 84896401230     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.22750     Document Type: Article

References (47)

1. Perez-Pedrero MJ, Sanchez-Casado M, Rodriguez-Villar S,. Nebulized colistin treatment of multi-resistant Acinetobacter baumannii pulmonary infection in critical ill patients. Medicina Intensiva 2011; 35: 226-231.
2. Maragakis LL, Perl TM,. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008; 46: 1254-1263.
3. Zavascki AP, Goldani LZ, Li J, Nation RL,. Polymyxin b for the treatment of multi-drug resistant pathogens: a critical review. J Antimicrob Chemother 2007; 60: 1206-1215.
4. Michalopoulos AS, Karatza DC,. Multi-drug resistant gram-negative infections: the use of colistin. Expert Rev Anti-infect Ther 2010; 8: 1009-1017.
5. Su BH, Hsieh HY, Chiu HY, Lin HC,. Nosocomial infection in a neonatal intensive care unit: a prospective study in Taiwan. Am J Infect Control 2007; 35: 190-195.
6. Dueñas L, Bran de Casares A, Rosenthal VD, Jesús Machuca L,. Device-associated infection rates in pediatric and neonatal intensive care units in El Salvador: findings of the INICC. J Infect Dev Ctries 2011; 5: 445-451.
7. Mai JY, Dong L, Lin ZL, Chen SQ,. [Investigation and analysis of nosocomial infection in neonates]. Zhonghua er ke za zhi Chinese J Pedia 2011; 49: 915-920.
8. Garnacho-Montero J, Ortiz-Leyba C, Fernandez-Hinojosa E, Aldabo-Pallas T, Cayuela A, Marquez-Vacaro JA, Garcia-Curiel A, Jimenez-Jimenez FJ,. Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intensive Care Med 2005; 31: 649-655.
9. Peleg AY, Seifert H, Paterson DL,. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21: 538-582.
10. Falagas ME, Siempos II, Bliziotis IA, Michalopoulos A,. Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials. Crit Care 2006; 10: R123.
11. Ioannidou E, Siempos II, Falagas ME,. Administration of antimicrobials via the respiratory tract for the treatment of patients with nosocomial pneumonia: a meta-analysis. J Antimicrob Chemother 2007; 60: 1216-1226.
12. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
13. Klepser ME,. Role of nebulized antibiotics for the treatment of respiratory infections. Curr Opin Infect Dis 2004; 17: 109-112.
14. Ventre K, Randolph AG,. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst Rev 2007; CD000181.
15. Brochet MS, McDuff AC, Bussieres JF, Caron E, Fortin G, Lebel D, Marcotte JE,. Comparative efficacy of two doses of nebulized colistimethate in the eradication of Pseudomonas aeruginosa in children with cystic fibrosis. Canadian Respir J 2007; 14: 473-479.
16. Ratjen F, Rietschel E, Kasel D, Schwiertz R, Starke K, Beier H, van Koningsbruggen S, Grasemann H,. Pharmacokinetics of inhaled colistin in patients with cystic fibrosis. J Antimicrob Chemother 2006; 57: 306-311.
17. Falagas ME, Sideri G, Korbila IP, Vouloumanou EK, Papadatos JH, Kafetzis DA,. Inhaled colistin for the treatment of tracheo-bronchitis and pneumonia in critically ill children without cystic fibrosis. Pediatr Pulmonol 2010; 45: 1135-1140.
18. Naesens R, Vlieghe E, Verbrugghe W, Jorens P, Ieven M,. A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug-resistant Pseudomonas aeruginosa. BMC Infect Dis 2011; 11: 317.
19. Nakwan N, Wannaro J, Thongmak T, Pornladnum P, Saksawad R, Chokephaibulkit K,. Safety in treatment of ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii with aerosolized colistin in neonates: a preliminary report. Pediatr Pulmonol 2011; 46: 60-66.
20. Gray JE, Richardson DK, McCormick MC, Workman-Daniels K, Goldmann DA,. Neonatal therapeutic intervention scoring system: a therapy-based severity-of-illness index. Pediatrics. 1992; 90: 561-567.
21. Gouyon JB, Guignard JP,. Management of acute renal failure in newborns. Pediatr Nephrol 2000; 14: 1037-1044.
22. Department of Health and Human Services. editor. Criteria for defining nosocomial pneumonia. http://www.cdc.gov/ncidod/hip/NNIS/members/pneumonia/ Final/PneumoCriteriaV1.pdf; August 23, 2006.
23. Wayne P,. Performance standards for antimicrobial susceptibility testing. Document M100-S17: Clinical Laboratory Standards Institute, 2007.
24. Paterson DL,. The epidemiological profile of infections with multi-drug resistant Pseudomonas aeruginosa and acinetobacter species. Clin Infect Dis 2006; 43: S43-S48.
25. Michalopoulos AS, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas ME,. Colistin treatment in patients with ICU-acquired infections caused by multi-resistant gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect 2005; 11: 115-121.
26. Falagas ME, Grammatikos AP, Michalopoulos A,. Potential of old-generation antibiotics to address current need for new antibiotics. Expert Rev Anti-infect Ther 2008; 6: 593-600.
27. Jensen T, Pedersen SS, Garne S, Heilmann C, Hoiby N, Koch C,. Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. J Antimicrob Chemother 1987; 19: 831-838.
28. Li J, Milne RW, Nation RL, Turnidge JD, Smeaton TC, Coulthard K,. Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate. J Antimicrob Chemother 2004; 53: 837-840.
29. Wolinsky E, Hines JD,. Neurotoxic and nephrotoxic effects of colistin patients with renal disease. N Engl J Med 1962; 266: 759-762.
30. Kallel H, Bahloul M, Hergafi L, Akrout M, Ketata W, Chelly H, Hamida CB, Rekik N, Hammami A, Bouaziz M,. Colistin as a salvage therapy for nosocomial infections caused by multi-drug resistant bacteria in the ICU. Int J Antimicrob Agents 2006; 28: 366-369.
31. Kallel H, Hergafi L, Bahloul M, Hakim A, Dammak H, Chelly H, Hamida CB, Chaari A, Rekik N, Bouaziz M,. Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study. Intensive Care Med 2007; 33: 1162-1167.
32. Markou N, Apostolakos H, Koumoudiou C, Athanasiou M, Koutsoukou A, Alamanos I, Gregorakos L,. Intravenous colistin in the treatment of sepsis from multi-resistant gram-negative bacilli in critically ill patients. Crit Care 2003; 7: R78-R83.
33. de Mendonca A, Vincent JL, Suter PM, Moreno R, Dearden NM, Antonelli M, Takala J, Sprung C, Cantraine F,. Acute renal failure in the ICU: risk factors and outcome evaluated by the sofa score. Intensive Care Med 2000; 26: 915-921.
34. Beringer P,. The clinical use of colistin in patients with cystic fibrosis. Curr Opin Pulm Med 2001; 7: 434-440.
35. Munoz-Price LS, Weinstein RA,. Acinetobacter infection. N Engl J Med 2008; 358: 1271-1281.
36. Dominguez-Ortega J, Manteiga E, Abad-Schilling C, Juretzcke MA, Sanchez-Rubio J, Kindelan C,. Induced tolerance to nebulized colistin after severe reaction to the drug. J Invest Allergol Clin Immunol 2007; 17: 59-61.
37. Parisi AF, Kaplan MH,. Apnea during treatment with sodium colistimethate. JAMA 1965; 194: 298-299.
38. McQuillen MP, Cantor HA, O'Rourke JR,. Myasthenic syndrome associated with antibiotics. Trans Am Neurol Assoc 1967; 92: 163-167.
39. Michalopoulos A, Fotakis D, Virtzili S, Vletsas C, Raftopoulou S, Mastora Z, Falagas ME,. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study. Respir Med 2008; 102: 407-412.
40. Arnold HM, Sawyer AM, Kollef MH,. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia. Respir Care 2012; 57: 1226-1233.
41. Falagas ME, Vouloumanou EK, Rafailidis PI,. Systemic colistin use in children without cystic fibrosis: a systematic review of the literature. Int J Antimicrob Agents 2009; 33: 503.e1-503.e13.
42. Iosifidis E, Antachopoulos C, Ioannidou M, Mitroudi M, Sdougka M, Drossou-Agakidou V, Tsivitanidou M, Roilides E,. Colistin administration to pediatric and neonatal patients. Eur J Pediatr 2010; 169: 867-874.
43. Jajoo M, Kumar V, Jain M, Kumari S, Manchanda V,. Intravenous colistin administration in neonates. Pediatr Infect Dis J 2011; 30: 218-221.
44. Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, Hale EC, Newman NS, Schibler K, Carlo WA, Kennedy KA, Poindexter BB, Finer NN, Ehrenkranz RA, Duara S, Sanchez PJ, O'Shea TM, Goldberg RN, Van Meurs KP, Faix RG, Phelps DL, Frantz ID III, Watterberg KL, Saha S, Das A, Higgins RD,. Neonatal outcomes of extremely preterm infants from the niched neonatal research network. Pediatrics 2010; 126: 443-456.
45. Hibbard JU, Wilkins I, Sun L, Gregory K, Haberman S, Hoffman M, Kominiarek MA, Reddy U, Bailit J, Branch DW, Burkman R, Gonzalez Quintero VH, Hatjis CG, Landy H, Ramirez M, VanVeldhuisen P, Troendle J, Zhang J,. Respiratory morbidity in late preterm births. JAMA 2010; 304: 419-425.
46. Agrafiotis M, Siempos II, Falagas ME,. Frequency, prevention, outcome and treatment of ventilator-associated tracheo-bronchitis: systematic review and meta-analysis. Respir Med 2010; 104: 325-336.
47. Celik IH, Oguz SS, Demirel G, Erdeve O, Dilmen U,. Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review. Eur J Pediatr 2012; 171: 311-316.